GlassScriptPhysician profile
Angela Palmer
NPI 1649699638
$13,440.93
in general payments reported to CMS, 2019-2025
23 companies · $1,751 in 2025
The $1,751 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $757 · 2022: $7,697 · 2023: $685 · 2024: $2,550 · 2025: $1,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,454 · Travel and Lodging: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,453.85 |
| Travel and Lodging | $533.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seaspine Orthopedics Corporation | $3,793.71 | 2021-2022 | |
| Providence Medical Technology, INC. | $3,517.13 | 2022-2025 | |
| Medtronic, INC. | $2,318.81 | 2022-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Spineology INC. | $546.15 | 2022 | |
| Nevro Corp. | $540.66 | 2021-2024 | Senza |
| Orthofix Medical, INC. | $533.00 | 2024 | 7d Surgical System, Mariner Mis, Mariner Mis Tlif Retractor |
| Abbott Laboratories | $393.86 | 2022-2023 | Proclaim, Penta |
| Kls-Martin L.P. | $382.93 | 2021-2022 | |
| Stryker Corporation | $274.28 | 2022-2025 | Universal Neuro 3, Duramatrix, Hydroset |
| Si-Bone, INC. | $226.62 | 2022 | |
| Intrinsic Therapeutics | $175.00 | 2025 | Barricaid Acd (Annular Closure Device) |
| Boston Scientific Corporation | $162.18 | 2024-2025 | General - Pain Management |
| Carlsmed, INC. | $131.46 | 2021 | |
| Genzyme Corporation | $123.23 | 2021 | |
| Forte Bio-Pharma LLC | $113.15 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $42.28 | 2022 | |
| Nico Corporation | $35.00 | 2024 | |
| Bioventus LLC | $31.80 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Biotronik Nro, INC. | $29.34 | 2025 | Prospera |
| Integra Lifesciences Corporation | $20.90 | 2021 | |
| Monteris Medical Corporation | $20.05 | 2025 | Neuroblate |
| Aesculap, INC. | $17.46 | 2025 | Aesculap |
| Saluda Medical Americas, INC. | $11.93 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.